TXN vs XENE · P/E 52, rev $10.29B vs $2.55B cap
Texas Instruments Incorporated (TXN) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
TXN currently screens at market cap $274.74B and trailing P/E 51.7. XENE currently screens at market cap $2.55B.
Not investment advice. Open the TXN and XENE stock pages for the full models.
Not investment advice.